Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Download White Paper
IT in
Healthcare,
Patient
Monitoring &
Telemedicine

Download White Paper

 
Matching geography
Reports matching your search in:
 
 
Download SlideShare
20
Hot
Stats on
Healthcare
IT

Download SlideShare

 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

1594
  • Biopharmaceuticals (366)
  • Diseases & Conditions (3413)
  • Drug Delivery (342)
  • Therapeutic Area (7481)
  • Vaccines (626)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 3  4  5  6  7  8  9  10  11  12  next >
Mundipharma International Limited – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Wilex AG – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Wilex AG’s corporate ...  |  read more...
$1,500.00
Momenta Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
MacroGenics, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate ...  |  read more...
$1,500.00
Generex Biotechnology Corporation – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Cytokinetics, Incorporated – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cytokinetics, Incorporated’s corporate ...  |  read more...
$1,500.00
ImmunoGen, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ImmunoGen, Inc.’s corporate ...  |  read more...
$1,500.00
BioMarin Pharmaceutical Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ...  |  read more...
$1,500.00
Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
CanBas Co., Ltd. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Iron Deficiency Anemia – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Iron Deficiency Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia. Iron Deficiency Anemia ...  |  read more...
$2,000.00
CytRx Corporation – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, CytRx Corporation’s corporate ...  |  read more...
$1,500.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
... market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and ...  |  read more...
$4,450.00
Skin Ulcers – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Skin Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Ulcers. Skin Ulcers - Pipeline Review, Half Year ...  |  read more...
$2,000.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
... of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, ...  |  read more...
$4,450.00
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
4/30/2013 | published by: GlobalData
... the Pharmaceutical Industry report provides a cross-section of major licensing deals between mid to large-sized pharmaceutical companies and academic and nonprofit research institutions. This report examines the terms, platform technologies, and deal rationale of 25 ...  |  read more...
$2,995.00
Motor Neurone Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Motor Neurone Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Motor Neurone Diseases. Motor Neurone Diseases ...  |  read more...
$2,000.00
Sanofi – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sanofi’s corporate website, SEC filings, investor ...  |  read more...
$1,500.00
NPS Pharmaceuticals, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Takeda Pharmaceutical Company Limited – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ...  |  read more...
$1,500.00
Advaxis, Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Advaxis, Inc.’s corporate ...  |  read more...
$1,500.00
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017
4/30/2013 | published by: GlobalData
... to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant unmet needs ...  |  read more...
$5,995.00
Astellas Pharma Inc. – Product Pipeline Review – 2013
4/30/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...  |  read more...
$2,000.00
< prev 3  4  5  6  7  8  9  10  11  12  next >